These results have central clinical significances as most chemotherapeutic methods focus on blocking cell-autonomous mechanisms without reflecting on the crosstalk between CICs and CAFs that may promote the specific CD44v6-signaling required for maintenance of CIC resistance and tumor recurrence through sustained WNT3A/β-catenin/TCF4 signaling. Here, WNT3A is linked to neoplasm.